Copyright
©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2019-2028
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2019
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2019
Figure 1 Effects of microbial metabolites on non-alcoholic fatty liver disease via the gut-liver axis.
SCFAs: Short-chain fatty acids; I3A: Indole-3-acetic acid; IPA: Indole propionic acid; GPR41/43: G-protein-coupled receptors 41/43; ZO-1: Zonula occludens 1; GLP-1: Glucagon-like peptide-1; PYY: Peptide YY; TLR4: Toll-like receptor 4; FMO3: Flavin-containing monooxygenase 3; TMAO: Trimethylamine-N-oxide; FXR: Farnesoid X receptor; TGR5: Takeda G-protein-coupled receptor 5; S1PR2: Sphingosine 1-phosphate receptor 2; BCAAs: Branched-chain amino acids.
- Citation: Zhou D, Fan JG. Microbial metabolites in non-alcoholic fatty liver disease. World J Gastroenterol 2019; 25(17): 2019-2028
- URL: https://www.wjgnet.com/1007-9327/full/v25/i17/2019.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i17.2019